Apple's new patent explores the future of Vision Pro headset: relieving pain for people with disabilities and helping them reduce drug dependence
王俊杰2017
发表于 2024-9-25 09:08:54
171
0
0
According to the latest list published by the US Patent and Trademark Office (USPTO), Apple has obtained a patent related to the Vision Pro headset, which describes the use of mixed reality technology to alleviate discomfort such as pain and reduce drug dependence. Apple's patent describes the use of the Vision Pro headset in the health field, which dynamically adjusts immersive content to shift the wearer's attention and alleviate discomfort.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Zaiding Medicine: Wei Weijia (Agamod) α Injection has been included in the national medical insurance drug catalog
- Bristol Myers Squibb announces acquisition of schizophrenia drug manufacturer Karuna for $14 billion
- Sanofi lipid-lowering drug Zhilida approved in China
- Musk responded to "drug use" by conducting a three-year randomized drug test in accordance with NASA's requirements
- Weight loss pills will bring benefits again! FDA assessment: Wegovy and other drugs are not associated with suicidal thoughts
- Nearly 800 drugs in the United States collectively raise prices. Novo Nordisk's "weight loss miracle drug" has risen by 3.5%
- Lilly plans to launch the obesity drug Telposide in India as early as next year
- Merck focuses on the development of next-generation cardiac metabolic drugs and competes with oral weight loss therapies
- GlaxoSmithKline agrees to pay up to $2.2 billion to resolve approximately 80000 lawsuits related to the heartburn drug Zantac
- GlaxoSmithKline agrees to pay up to $2.2 billion to resolve approximately 80000 lawsuits related to the heartburn drug Zantac
